Medikit Co.,Ltd. (TYO:7749)
2,806.00
-44.00 (-1.54%)
Jun 2, 2026, 2:47 PM JST
Medikit Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 20,952 | 21,559 | 23,611 | 27,592 | 28,118 |
Cash & Short-Term Investments | 20,952 | 21,559 | 23,611 | 27,592 | 28,118 |
Cash Growth | -2.82% | -8.69% | -14.43% | -1.87% | 2.28% |
Receivables | 5,111 | 5,059 | 5,285 | 5,691 | 5,004 |
Inventory | 5,481 | 4,567 | 3,877 | 3,281 | 3,626 |
Restricted Cash | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
Other Current Assets | 171 | 558 | 218 | 112 | 293 |
Total Current Assets | 33,215 | 33,243 | 34,491 | 38,176 | 38,541 |
Property, Plant & Equipment | 14,943 | 14,447 | 11,474 | 10,438 | 10,834 |
Long-Term Investments | 2,058 | 1,237 | 1,248 | 1,077 | 1,136 |
Goodwill | 1,902 | 2,120 | 2,337 | 1,935 | - |
Other Intangible Assets | 1,051 | 1,163 | 1,138 | 1,157 | 126 |
Long-Term Deferred Tax Assets | 101 | 259 | 310 | 402 | 419 |
Other Long-Term Assets | 2 | 1 | 1 | 1 | 1 |
Total Assets | 53,272 | 52,470 | 50,999 | 53,186 | 51,057 |
Accounts Payable | 2,607 | 3,469 | 3,180 | 2,545 | 2,575 |
Accrued Expenses | 419 | 423 | 412 | 413 | 397 |
Current Portion of Leases | 5 | - | - | - | - |
Current Income Taxes Payable | 806 | 866 | 897 | 765 | 604 |
Other Current Liabilities | 1,476 | 1,401 | 1,229 | 950 | 838 |
Total Current Liabilities | 5,313 | 6,159 | 5,718 | 4,673 | 4,414 |
Long-Term Leases | 13 | - | - | - | - |
Pension & Post-Retirement Benefits | - | - | - | 86 | 84 |
Long-Term Deferred Tax Liabilities | 332 | 340 | 336 | 330 | - |
Other Long-Term Liabilities | 834 | 816 | 817 | 806 | 788 |
Total Liabilities | 6,492 | 7,315 | 6,871 | 5,895 | 5,286 |
Common Stock | 1,241 | 1,241 | 1,241 | 1,241 | 1,241 |
Additional Paid-In Capital | 8,385 | 8,378 | 8,432 | 10,384 | 10,378 |
Retained Earnings | 38,957 | 37,340 | 39,826 | 38,519 | 37,165 |
Treasury Stock | -2,929 | -2,545 | -6,046 | -3,243 | -3,256 |
Comprehensive Income & Other | 1,126 | 741 | 675 | 390 | 243 |
Shareholders' Equity | 46,780 | 45,155 | 44,128 | 47,291 | 45,771 |
Total Liabilities & Equity | 53,272 | 52,470 | 50,999 | 53,186 | 51,057 |
Total Debt | 18 | - | - | - | - |
Net Cash (Debt) | 20,934 | 21,559 | 23,611 | 27,592 | 28,118 |
Net Cash Growth | -2.90% | -8.69% | -14.43% | -1.87% | 2.28% |
Net Cash Per Share | 1437.13 | 1463.41 | 1445.78 | 1643.95 | 1673.59 |
Filing Date Shares Outstanding | 14.49 | 14.62 | 14.8 | 16.79 | 16.78 |
Total Common Shares Outstanding | 14.49 | 14.62 | 14.8 | 16.79 | 16.78 |
Working Capital | 27,902 | 27,084 | 28,773 | 33,503 | 34,127 |
Book Value Per Share | 3229.12 | 3089.51 | 2982.53 | 2817.14 | 2727.96 |
Tangible Book Value | 43,827 | 41,872 | 40,653 | 44,199 | 45,645 |
Tangible Book Value Per Share | 3025.28 | 2864.88 | 2747.66 | 2632.95 | 2720.45 |